Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1992;20:158-167

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishimura, M.
Right arrow Articles by Ferrario, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishimura, M.
Right arrow Articles by Ferrario, C. M.

Hypertension, Vol 20, 158-167, Copyright © 1992 by American Heart Association


ARTICLES

Tissue renin-angiotensin systems in renal hypertension

M Nishimura, A Milsted, CH Block, KB Brosnihan and CM Ferrario
Department of Brain and Vascular Research, Cleveland Clinic Foundation, Ohio 44195.

Angiotensinogen messenger RNA (mRNA) levels were measured in the brain (hypothalamus, lower brain stem, cerebellum), liver, kidneys, and adrenal glands of rats made hypertensive by ligation of the aorta between the renal arteries. We also measured renin mRNA in the kidneys of these renal hypertensive rats. The early phase of hypertension (day 6) was associated with significant increases in plasma renin activity and levels of circulating angiotensin II. The circulating renin- angiotensin system was not activated in the later phase of hypertension (day 24). Angiotensinogen mRNA levels were elevated in the lower brain stem of hypertensive rats at both stages of hypertension. In contrast, angiotensinogen mRNA levels in the hypothalamus were increased only at day 6 after aortic ligation. Decreased levels of angiotensinogen mRNA were observed in the cerebellum in both the early and later phases of the hypertension. Angiotensinogen mRNA levels in the adrenal gland below the ligature fell in the early phases but rose in the later phases of hypertension. Renin mRNA levels of the ischemic kidney remained elevated at both the early and later phases, whereas in both ischemic and nonischemic kidneys, levels of angiotensinogen mRNA remained below sham values throughout the period of study. These results indicate differential expression of renin-angiotensin system mRNAs in tissues of renal hypertensive rats. The differential changes in the expression of angiotensinogen mRNA over the course of development and maintenance of renal hypertension suggest that factors in addition to angiotensin II are important in modulating the expression of renin-angiotensin system genes.


This article has been cited by other articles:


Home page
HypertensionHome page
J. V. C. Felix and L. C. Michelini
Training-Induced Pressure Fall in Spontaneously Hypertensive Rats Is Associated With Reduced Angiotensinogen mRNA Expression Within the Nucleus Tractus Solitarii
Hypertension, October 1, 2007; 50(4): 780 - 785.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. deS. Senanayake, J. Drazba, K. Shadrach, A. Milsted, E. Rungger-Brandle, K. Nishiyama, S.-I. Miura, S. Karnik, J. E. Sears, and J. G. Hollyfield
Angiotensin II and Its Receptor Subtypes in the Human Retina
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3301 - 3311.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. A. Silva, A. W. Chan, C. J. White, T. J. Collins, J. S. Jenkins, J. P. Reilly, and S. R. Ramee
Elevated Brain Natriuretic Peptide Predicts Blood Pressure Response After Stent Revascularization in Patients With Renal Artery Stenosis
Circulation, January 25, 2005; 111(3): 328 - 333.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Lazartigues, A. J. Lawrence, F. S. Lamb, and R. L. Davisson
Renovascular Hypertension in Mice With Brain-Selective Overexpression of AT1a Receptors Is Buffered by Increased Nitric Oxide Production in the Periphery
Circ. Res., September 3, 2004; 95(5): 523 - 531.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. P. R. Klett, D. Anderson, M. Sholook, and J. P. Granger
Antisense oligodeoxynucleotides directed against a novel angiotensinogen mRNA-stabilizing protein reduce blood pressure in spontaneously hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R619 - R626.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Morimoto, M. D. Cassell, and C. D. Sigmund
Glia- and Neuron-specific Expression of the Renin-Angiotensin System in Brain Alters Blood Pressure, Water Intake, and Salt Preference
J. Biol. Chem., August 30, 2002; 277(36): 33235 - 33241.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. P. R. Klett and J. P. Granger
Physiological elevation in plasma angiotensinogen increases blood pressure
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1437 - R1441.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Kagiyama, A. Varela, M. I. Phillips, and S. M. Galli
Antisense Inhibition of Brain Renin-Angiotensin System Decreased Blood Pressure in Chronic 2-Kidney, 1 Clip Hypertensive Rats
Hypertension, February 1, 2001; 37(2): 371 - 375.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Nishimura, K. Ohtsuka, H. Takahashi, and M. Yoshimura
Role of FMRFamide-Activated Brain Sodium Channel in Salt-Sensitive Hypertension
Hypertension, January 1, 2000; 35(1): 443 - 450.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Nishimura, K. Ohtsuka, N. Iwai, H. Takahashi, and M. Yoshimura
Regulation of brain renin-angiotensin system by benzamil-blockable sodium channels
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1416 - R1424.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. L. Davisson, G. Yang, T. G. Beltz, M. D. Cassell, A. K. Johnson, and C. D. Sigmund
The Brain Renin-Angiotensin System Contributes to the Hypertension in Mice Containing Both the Human Renin and Human Angiotensinogen Transgenes
Circ. Res., November 16, 1998; 83(10): 1047 - 1058.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Nishimura, K. Ohtsuka, A. Nanbu, H. Takahashi, and M. Yoshimura
Benzamil blockade of brain Na+ channels averts Na+-induced hypertension in rats
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R635 - R644.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Milsted, M. Nishimura, K. B. Brosnihan, and C. M. Ferrario
Differential Regulation of Angiotensinogen Transcripts After Renin Infusion
Hypertension, October 1, 1996; 28(4): 678 - 681.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. G. Melaragno and G. D. Fink
Enhanced Slow Pressor Effect of Angiotensin II in Two-Kidney, One Clip Rats
Hypertension, February 1, 1995; 25(2): 288 - 293.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. Morimoto, M. D. Cassell, and C. D. Sigmund
The Brain Renin-Angiotensin System in Transgenic Mice Carrying a Highly Regulated Human Renin Transgene
Circ. Res., January 11, 2002; 90(1): 80 - 86.
[Abstract] [Full Text] [PDF]